Merit Medical Systems has enrolled the first patient in the multi-centre PREEMIE study to assess the efficacy and safety of the Bloom Micro Occluder System, aimed at treating patent ductus arteriosus ...

Merit Medical aims to improve care for vulnerable premature infants by evaluating the safety and efficacy of the Bloom Micro Occluder System for treating PDA in the specified patient pool.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder ...